Real‐world effectiveness and safety of insulin glargine 300 U/ml in insulin‐naïve people with type 2 diabetes in the Latin America region: A subgroup analysis of the ATOS - Vargas‐Uricoechea - 2023 -
It's incumbent upon us to push the science' in mRNA: Sanofi CEO
Dorflex Icy Hot® Flexible Patch
Sanofi throws weight behind ALS startup QurAlis in $88M round - Boston Business Journal
Sanofi Brasil - Conheça nosso novo Canal de Atendimento ao... | Facebook
Le laboratoire Sanofi affiche des résultats en hausse en 2021 et se dit «confiant» pour 2022 - Le Parisien
Sanofi on Twitter: "What can the G20 do to support the fight against pandemics in a globalized world? Hear from David Loew, @SanofiPasteur Executive Vice President, who attended @glob_solutions #GlobalSolutionSummit today: https://t.co/pJEAHw25WU #